ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App
Shots: Ribometrix to get $20M up front including an equity investment in the company with $700M as development, regulatory and commercial milestones and royalties on sales on any product. Vertex to discover two programs in collaboration with Ribometrix and has an option to add the third program & to take exclusive WW license for the […]Read More
